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Abstract
Background: Nontyphoidal Salmonella is the main cause of human salmonellosis. In order to study
the prevalent serogroups and serovars of clinical isolates in Taiwan, 8931 Salmonellae isolates were
collected from 19 medical centers and district hospitals throughout the country from 2004 to 2007.
The pulsed-field eletrophoresis types (PFGE) and antibiotic resistance profiles of Salmonella enterica
serovars Bareilly (S. Bareilly) and Braenderup (S. Braenderup) were compared, and multi-drug
resistance (MDR) plasmids were characterized.
Results: Over 95% of human salmonellosis in Taiwan was caused by five Salmonella serogroups: B,
C1, C2-C3, D1, and E1. S. Typhymurium, S. Enteritidis, S. Stanley and S. Newport were the four
most prevalent serovars, accounting for about 64% of isolates. While only one or two major
serovars from four of the most prevalent serogroups were represented, four predominant
serovars were found in serogroup C1 Salmonellae. The prevalence was decreasing for S.
Choleraeuis and S. Braenderup, and S. Virchow and increasing for S. Bareilly. S. Braenderup mainly
caused gastroenteritis in children; in contrast, S. Bareiley infected children and elderly people. Both
serovars differed by XbaI-PFGE patterns. Almost all S. Bareilly isolates were susceptible to
antibiotics of interest, while all lacked plasmids and belonged to one clone. Two distinct major
clones in S. Braenderup were cluster A, mainly including MDR isolates with large MDR plasmid
from North Taiwan, and cluster B, mainly containing susceptible isolates without R plasmid from
South Taiwan. In cluster A, there were two types of conjugative R plasmids with sizes ranging from
75 to 130 kb. Type 1 plasmids consisted of replicons F1A/F1B, blaTEM, IS26, and a class 1 integron
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with the genes dfrA12-orfF-aadA2-qacEΔ1-sulI. Type 2 plasmids belonged to incompatibility group
IncI, contained tnpA-blaCMY-2-blc-sugE genetic structures and lacked both IS26 and class 1 integrons.
Although type 2 plasmids showed higher conjugation capability, type 1 plasmids were the
predominant plasmid.
Conclusions: Serogroups B, C1, C2-C3, D1, and E1 of Salmonella caused over 95% of human
salmonellosis. Two prevalent serovars within serogroup C1, S. Bareilly and cluster B of S.
Braenderup, were clonal and drug-susceptible. However, cluster A of S. Braenderup was MDR and
probably derived from susceptible isolates by acquiring one of two distinct conjugative R plasmids.
Background
Non-typhoidal Salmonellae are major zoonotic pathogens
that commonly cause salmonellosis outbreaks. Globally,
salmonellosis caused by non-typhoidal salmonellae gen-
erally results in about 1.3 billion cases of acute gastroen-
teritis and 3 million deaths annually [1]. In the United
States, Salmonellae cause an estimated 1.4 million cases of
salmonellosis and over 500 deaths annually [2]. Multi-
drug resistant (MDR) Salmonella, the global spread of
which is mediated by international food trade and travel,
is a global public health issue [3,4]. Often, clonal spread
of MDR strains has been observed in particular serovars
[4-6]. In most instances, resistance genes often associated
with integrons and/or transposons are clustered within
antimicrobial resistance islands that can be horizontally
transferred by conjugative or mobilization plasmids [7].
In serogroup C1, S. Bareilly and S. Braenderup are closely
related according to molecular analysis [8,9]. Both serov-
ars have been highly susceptible to antimicrobials since
1971 [10,11] and are frequently isolated from feces of
people with food-borne salmonellosis all over the world
[12-16]. However, prevalence of both serovars differs
between hosts and regions. In Denmark, S. Bareilly was
isolated from diverse sources, including humans, animals
and animal feed, while S. Braenderup was only found in
humans [17]. In a study of a broiler-raising plant in the
USA, S. Bareilly was often found in broilers and finished
feed; however, S. Braenderup was only observed in hatch-
eries [18]. In addition, S. Braenderup was commonly iso-
lated from cattle and turtles in Sweden [19], pigs [12] and
chicken egg shells [20] in USA. These findings imply that
animal reservoirs may be important sources of both sero-
vars in human disease.
In this study, prevalent serogroups and serovars were
determined for 8,931 Salmonella isolates collected from
2004 and 2007 in Taiwan. Because of the genetic similar-
ity between S. Bareilly and S. Braenderup [8,9], the two
serovars were compared with respect to antimicrobial
resistance, resistance genes, PFGE and plasmid profiles.
Both serovars disseminated clonally and varied in antimi-
crobial resistance patterns.
Results
Prevalent serogroups and serovars
Between 2004 and 2007, over 95% of 8,931 Salmonella
isolates belonged to serogroups B, C1, C2-C3, D1 and E1
(Table 1). Prevalence differed between serogroups and
across time within serogroups: prevalence decreased in
serogroups B (46.9%→42.4%) and C1 (14.2%→9.1%)
and increased in serogroups C2-C3 (9%→11.3%) and D1
(23.3%→30.2%) over the study period. Such changes
were associated with the prevalence of major serovars in
each serogroup and were due to only one or two main pre-
dominant serovars in each serogroup, except serogroup
C1 with four prevalent serovars (Table 1). The top four
serovars were S. Enteritidis (22.9-28.9%) of serogroup
D1, S. Typhimurium (20.4-24.7%) and S. Stanley (8.2-
11.4%) of serogroup B, and S. Newport of serogroup C2
(5.6 - 7.3%). In contrast to the decrease in prevalence of S.
Typhimurium from 2005 to 2007, a gradual increase in
prevalence was observed in S. Enteritidis.
Prevalence of serogroup C1 serovars
S. Braenderup, S. Choleraesuis, S. Bareilly and S. Virchow
were the predominant serovars in serogroup C1 and con-
sisted of 66 - 84% of total serogroup C1 isolates from
2004 to 2007 (Table 1). Other serovars, including S.
Infantis, S. Potsdam, S. Mbandaka, and S. Montevideo,
were occasionally isolated with prevalence less than 1%
for each serovar. Over the study period, the prevalence of
S. Choleraesuis declined dramatically, and S. Braenderup
prevalence declined mildly. In contrast, the prevalence of
S. Bareilly and other serovars gradually increased from
2004 to 2007. Since S. Braenderup and S. Bareilly were the
two main serogroup C1 serovars in 2006-2007 and dif-
fered in prevalence trends, 45 S. Braenderup and 51 S.
Bareilly isolates were analyzed for their antimicrobial
resistance profiles and genetic characteristics.
Age distribution of patients
Patients infected with S. Braenderup and S. Bareilly were
separated into four age groups. Although, both serovars
were found primarily to infect children (age ≤ 4 years), S.
Bareilly was isolated far more frequently from the elderly
(age ≥ 50 years) (8.9% for S. Braenderup vs. 31.4% for S.BMC Microbiology 2009, 9:264 http://www.biomedcentral.com/1471-2180/9/264
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Bareilly, p < 0.05) (Table 2). However, S. Braenderup was
predominantly isolated from children (68.9% for S.
Braenderup vs. 49% for S. Bareilly, p < 0.05).
PFGE phylogenetic analysis
The clustering analysis of XbaI-digested PFGE patterns
demonstrated genetic differences between S. Braenderup
and S. Bareilly and within each serovar (Figure 1). In S.
Braenderup, all isolates were separated into 2 clusters (I
and II) at S = 0.68. Most isolates belonged to cluster I,
which was further separated into two subgroups (A and B)
at S = 0.84 (Figure 1A). In cluster A, 19 isolates were sep-
arated into 9 PFGE patterns, and 78.9% (15/19) of the
isolates were from northern Taiwan (Figure 1A). In cluster
B, 25 isolates were grouped into 4 PFGE patterns, and
72% (18/25) of the isolates were from southern Taiwan
(Figure 1A). S. Bareilly isolates were highly genetically
homogenous and shared more than 90% pattern similar-
ity (Figure 1B).
Antimicrobial resistance profiles
Among six traditional antibiotics tested, S. Braenderup
and S. Bareilly isolates were almost all susceptible to chlo-
ramphenicol (CHL; 6.7% for S. Braenderup vs 0% for S.
Bareilly) and kanamycin (KAN; 4.4% vs 0%) and differed
significantly in resistance to ampicillin (AMP, 37.7% for
S. Braenderup vs 0% for S. Bareilly), nalidixic acid (NAL;
0% vs 15.7%), streptomycin (STR, 37.7% vs 15.7%), and
tetracycline (TET; 33.3% vs 0%) (Figure 1). Additionally,
Table 1: Prevalence of Salmonella serogroups and their main serovars isolated from human from 2004 to 2007.
Serogroup/Serovar Number of isolates Prevalence (%)2
2004 2005 2006 2007 Total 2004 2005 2006 2007 Total
Serogroup B 1133 1045 938 854 3970 44.3 46.9 44.0 42.4 44.5
S. Typhimurium 571 551 441 412 1975 22.3ab 24.7a 20.7b 20.4b 22.1ab
S. Stanley 287 183 242 168 880 11.2 8.2 11.4 8.3 9.9
Serogroup C1 364 229 234 184 1101 14.2 10.3 11.0 9.1 11.3
S. Choleraesuis 111 65 30 17 223 4.3
(30.5)
2.9
(28.4)
1.41
(12.8)
0.84
(9.23)
2.50
(22.6)
S. Braenderup 96 46 66 32 240 3.8
(26.4)
2.1
(20.9)
3.1
(28.2)
1.6
(17.4)
2.7
(23.7)
S. Bareilly 54 41 47 54 196 2.1
(14.8)
1.8
(17.9)
2.2
(20.1)
2.7
(29.4)
2.2
(19.4)
S.  V i r c h o w 4 33 43 31 91 2 91 . 7
(11.8)
1.5
(14.8)
1.6
(14.1)
0.9
(10.3)
1.4
(12.8)
Other serovars1 60 43 58 62 223 2.3
(16.5)
1.9
(18.8)
2.7
(24.8)
3.1
(33.7)
2.5
(22.1)
Serogroup C2-C3 231 246 239 228 944 9.0 11.0 11.2 11.3 10.6
S. Newport 144 137 135 147 563 5.6 6.1 6.3 7.3 6.3
S. Albany 87 109 104 81 381 3.4 4.9 4.9 4.0 4.3
Serogroup D 597 550 583 609 2339 23.3 24.7 27.4 30.2 26.2
S. Enteritidis 586 543 567 582 2278 22.9c 24.4bc 26.6ab 28.9a 25.5
Serogroup E1 122 76 64 70 332 4.8 3.4 3.0 3.5 3.7
S. Weltevreden 94 61 556 62 273 3.7 2.7 2.6 3.1 3.1
Sum3 2447 2147 2058 1954 8736 95.6 96.3 96.6 96.5 96.3
Total Salmonellae 2,557 2,228 2,131 2,015 8,931
1Other serogroup C1 serovars include are mainly S. Infantis, S. Potsdam, S. Mbandaka, and S. Montevideo.
2Numbers in parenthesis indicate the percentage of isolates of a C1 serovar over total serogroup C1 isolates.
3Sum is the total number of serogroup B, C1, C2-C3, D, and E isolates.
abcDifferent letters indicate significant difference between years.
Table 2: Age prevalence of patient infected by S. Bareilly and S. 
Braenderup
Rate (%) of each age group
Serovar 0 ~ 4 5 ~ 12 13 ~ 50 > 50
S. Bareilly 49.0b
(25/51)
9.8
(5/51)
9.8
(5/51)
31.4b
(16/51)
S. Braenderup 68.9a
(31/45)
8.9
(4/45)
13.3
(6/45)
8.9a
(4/45)
abDifferent letters indicate significant difference between S. Bareilly 
and S. Braenderup (Pp<0.05).BMC Microbiology 2009, 9:264 http://www.biomedcentral.com/1471-2180/9/264
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Dendrograms were constructed by PFGE-XbaI patterns to determine the genotypes for S. Braenderup (A) and S. Bareilly (B)  with corresponding information including the number and size of plasmids, PFGE subtypes, antimicrobial resistance patterns  and collection location of each isolate Figure 1
Dendrograms were constructed by PFGE-XbaI patterns to determine the genotypes for S. Braenderup (A) and 
S. Bareilly (B) with corresponding information including the number and size of plasmids, PFGE subtypes, anti-
microbial resistance patterns and collection location of each isolate. The dendrograms were generated by the 
unweighted pair group method with arithmetic mean (UPGMA) using the Dice-predicted similarity value of two patterns. The 
BioNumerics version 4.5 statistics program was used with settings of 1.0% optimization and 0.7% tolerance. Symbols of black 
square and white square represent resistant and susceptible respectively. Plasmids were separated into four groups by size. Ex, 
1, 1, 1, 3 indicates that this strain harbored 6 plasmids, one is >90 kb, one is from >50 to <90 kb, one is from >6.6 to <50 kb, 
and three are <6.6 kb.
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Table 3: Characteristics of MDR plasmids from 17 S. Braenderup isolates.
Antimicrobial resistance gene
Strains Plasmid
RFLP
profile
Antibiogram1 aadA2 blaTEM blaCMY-2 Plasmid
size
(kb)
Conjugation 
rate
Inc3 Class I 
integron
IS26 Month of 
isolation
Number of 
isolates
S. Braenderup 2 1a ACKTSSxt + + - 137.4 4.22 × 10-6 F1A/1B + ND 2004.8 2
E. coli/p2 ACKSxtT +
S. Braenderup 96 1a ACKSSxtT + + - 137.4 6.04 × 10-6 F1A/1B + ND 2004.8
E. coli/p96 ACKSxtT +
S. Braenderup 24 1b ASSxt + + - 122.6 8.25 × 10-6 F1A/1B + ND 2004.8 1
E. coli/p24 ASxt +
S. Braenderup 874 1d ASSxtT + + - 102.5 -- F1A/1B + ND 2004.7 7
E. coli/p30 ASxt +
S. Braenderup 12 1e ASSxtT + + - 99.1 - F1A/1B + ND 2005.4 3
E. coli/p12 ASxt +
S. Braenderup 11 1g ASxtT - + - 104.4 - F1A/1B - ND 2005.1 1
E. coli/p11 ASxt +
S. Braenderup 13 ACSSxtT + + + + ND 2004.7
E. coli/p13-1 A - - + 75.5 8.41 × 10-2 IncI1 - - 1
E. coli/p13-2 1f ACSxtT + + - 127.8 - F1A/1B + + 1
S. Braenderup 32 ASSxtT + + + + ND 2005.9
E. coli/p32-1 2a A - - + 75.5 8.66 × 10-2 IncI1 - - 1
E. coli/p32-2 1d ASxt + + - 102.5 ND F1A/1B + + 1
S. Braenderup 36 ASSxtT + + + + ND 2005.5
E. coli/36-1 2b A - - + 85 1.28 × 10-1 IncI1 - - 1
E. coli/p36-2 1c ASxt + + - 104.8 - F1A/1B + + 1
1Abbreviation: A, ampicillin; C, chloramphenicol; K, kanamycin; S, streptomycin; Sxt, trimethoprim-sulfamethoxazole; T, tetracycline.
2ND, not determined; +, conjugative; -, .non-conjugative.
3Inc, plasmid incompatibility group.
4Other 6 isolates 30 from 2005/2, 31 from 2004/10, 35 from 2005/7, 37 from 2005/3, 44 from 2004/6, and 82 from 2004/7 were not tested for conjugation.
5Other 2 isolates 15 from 2005/5 and 21 from 2004/9 were not tested for conjugation.BMC Microbiology 2009, 9:264 http://www.biomedcentral.com/1471-2180/9/264
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nine resistance patterns were determined, ranging from
susceptibility to all antimicrobials to resistance to four
antimicrobials. In S. Braenderup, 7 resistance patterns (S,
R2, R4 to R8) were found, and significant differences were
observed between cluster A (patterns R2, R4-R8) and B
(patterns S and R2) for AMP (77.3% vs 0%), STR (63.6%
vs 13%) and TET (54.5% vs 13%). In addition, most iso-
lates in cluster A were MDR (73.7%) while most isolates
in cluster B were susceptible (84%). In cluster A, pattern
R6 (AMP, TET, and STR) was the predominant and was
found in four genotypes (A3, A5, A6, and A7). In S.
Bareilly, most isolates were either susceptible (S pattern;
52.9%) or resistant to one (pattern R1 and R2; 31.4% and
9.8%, respectively) or two (pattern R3; 5.9%) antimicro-
bials. NAL resistant isolates were found in S. Bareilly (pat-
terns R2 and R3) but not in S. Braenderup. Since there
were susceptible to levofloxacin (LEV) and moxifloxacin
(MOX), NAL resistance may result from a mutation in the
gyrA gene, which encodes a subunit of the enzyme DNA
gyrase.
Characterization of MDR plasmids
The prevalence of plasmid profile determined by plasmid
number and size differed between these two serovars.
Most S. Braenderup isolates [93.3%, (42/45)] carried plas-
mids, while few S. Bareilly isolates [23.5 % (12/51)] did
(Figure 1). Plasmids larger than ca.75 kb were only found
in resistance isolates of cluster A with the R4 to R8 pat-
terns. Cluster B S. Braenderup isolates and S. Bareilly iso-
lates carried smaller plasmids with the size smaller than
6.6 kb or lacked plasmids. Larger plasmids were further
identified as R plasmids by analysis of the antimicrobial
resistance profiles of E. coli pir116 transformants, and
assigned to type 1 and 2 based on HindIII-restriction pat-
terns (Table 3, Figure 2). Further conjugation, antibiotic
resistance and PCR characterization of incompatibility
and oriT types, mobile element IS26, class 1 integron, and
AMP resistance genes blaTEM and blaCMY-2 were performed
for these two plasmid types. Type 1 plasmids were sepa-
rated into 7 subtypes (1a ~1g) based on differences in
plasmid size ranging from 99.1 kb to 137.4 kb and restric-
tion pattern. All plasmids carried blaTEM, replicons F1A
and F1B, IS26, and a class 1 integron (Additional files 1
and 2: Figure S1 and S2) with a gene cluster of dfrA12-orfF-
aadA2-qacEΔ1-sulI, conferring resistance to trimethoprim-
sulfamethoxazole (Sxt) and disappearing in plasmid 1 g
(Table 3), which apparently coincides with that in the
plasmid of S. Typhimurium (Accession number
AB365868). The size of R plasmid was associated with
antimicrobial resistance and conjugation capability
(Table 3). Only type 1a plasmids, with a size of 137.4 kb
and conferring resistance to AMP, CHL, KAN, Sxt and TET,
and 1b plasmids, with a size of 122.6 kb and encoding
resistance to AMP and Sxt, were capable of conjugation,
with efficiencies ranging 4.22 ~ 8.25 × 10-6. The other
smaller plasmids, with sizes ranging from 99.1 kb to
104.8 kb and encoding resistance to AMP and Sxt for 1c-
1e and 1g, and to AMP, CHL, Sxt and TET for 1f, were not
capable of conjugation. Due to differences in plasmid size
and since IS26 could be involved in plasmid transposition
and recombination, we performed PCR amplification
with the IS26 in primers and IS26out primers for all type
1 plasmids (Figure 3). In contrast to a 1.1-kb PCR product
in the largest 1a plasmid, 1b, 1d, and 1e plasmids lacked
any PCR products; 1e and 1g plasmids presented 3.1 kb
PCR products; and 1c plasmid yielded two PCR products
with sizes of 3.1 kb and 0.7 kb. These results suggest that
the number of IS26 and/or distance between two IS26 ele-
ments differed among these type 1 plasmids. In contrast
to type 1 plasmids, type 2 plasmids were much smaller in
size (77.5 kb and 85 kb) and had higher conjugation effi-
ciencies, ranging from 8.41 × 10-2 to 1.28 × 10-1 (Table 3).
In addition, type 2 plasmids were the IncI1 plasmid and
contained oriT as well as tnpA-blaCMY-2-blc-sugE (Table 3,
Additional files 3: Figure S3).
Discussion
Human salmonellosis was limited to five Salmonella sero-
groups: B, C1, C2-C3, D1, and E1 (Table 1). Despite the
decrease in prevalence of S. Typhimurium and the
increase in the prevalence of S. Enteritidis from 2005 to
2007, serogroups B and D Salmonellae  were the major
pathogens for foodborne salmonellosis in Taiwan due to
HindIII-digested RFLP profiles of ampicillin resistance plas- mids in S. Braenderup isolates Figure 2
HindIII-digested RFLP profiles of ampicillin resist-
ance plasmids in S. Braenderup isolates. M1: HindIII-
digested lambda DNA size marker. M2: 1 kb size marker.BMC Microbiology 2009, 9:264 http://www.biomedcentral.com/1471-2180/9/264
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S. Typhimurium, S. Stanley, and S. Enteritidis of sero-
group D1 being the three most prevalent serovars overall.
Although the prevalence of serogroups C1 and C2-C3
were similar (around 11%), 4 prevalent serovars and 2
main serovars were found in serogroup C1 and serogroup
C2-C3, respectively. In the present study, a shift in preva-
lence was observed in these four prevalent serogroup C1
serovars: a rapidly decrease in the prevalence of S. Chol-
eresuis, mainly due to enhancement of sanitation and
control of swine in Taiwan, and an increase in prevalence
of S. Bareilly and other serovars (Table 1). Compared to
the 1.6% increase in the prevalence of S. Braenderup from
1978 to 1987 in southern Taiwan [21], the change in the
prevalence of isolates in this study ranged from 1.6% to
3.8%, with a trend of decrease from 2004 to 2007, except
an increase of S. Braenderup infection in 2006 (Table 1),
suggesting possibly occurrence of outbreaks in this year.
Contrary to earlier reports that S. Bareilly and S.
Braenderup are closely related genetically [8,9], resistant
to 10 Salmonella bacteriophages [22], and infect immuno-
compromised patients, differences between S. Braenderup
and S. Bareilly were found in the prevalence trend from
2004 to 2007 (Table 1), patients' age group (Table 2), and
plasmid profile as well as antimicrobial resistance groups
and XbaI-PFGE patterns (Figure 1A). In addition to genetic
differences between these two serovars, differences in ani-
mal hosts were also observed in both serovars based on
the geographic regions from which they were isolated
[13,17,18,23]. In this study, we found that S. Bareilley iso-
lates were highly homogeneous genetically and that S.
Braenderup isolates were much diverse in our PFGE and
plasmid analysis (Figure 1). This may explain why S.
Braenderup, but not S. Bareilly, has been frequently
reported [19,20,24]. To differentiate S. Braenderup, sev-
PCR amplification of IS26 and IS26-associated DNA fragments Figure 3
PCR amplification of IS26 and IS26-associated DNA fragments. (A) Primer design. Symbols of arrow and dashed 
arrow represent IS26in primers and IS26out primers, respectively. (B) PCR products amplified by IS26in primers. (C) PCR 
products amplified by IS26out primers. M1: 100-bp size marker. N: negative control. M2: 1-kb size marker.
M1  N   P  2 11  12  13-1  13-2  15  21  24  M2  M1  30  31 32-1 32-2  35  36-1 36-2 37  44  82  87 
IS26 IS26 IS26 A.
B.
C.  Plasmid Type 
 M1  N  1g  1e  1f   1b  1d  1c  1a  M2BMC Microbiology 2009, 9:264 http://www.biomedcentral.com/1471-2180/9/264
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eral molecular methods have been developed, including
phage typing [25] and plasmid analysis as performed in
this study (Table 1, Figure 1 and 2).
Unlike MDR S. Choleraesuis isolated from pigs and
humans [5,6], S. Braenderup and S. Bareilly isolated from
pigs were highly susceptible to antibiotics in 1971 [10]. In
addition, in a study of resistance to 11 antibiotics for Sal-
monella isolated from turtles, S. Bareilly was still suscepti-
ble to all antibiotics, and, in contrast, few S. Braenderup
isolates were resistant to gentamycin (6/15), sulfisoxazole
(6/15) and TET (2/15) [11]. In our study, almost all of the
cluster A isolates of S. Braenderup were MDR and associ-
ated with large MDR plasmids (Table 3, Figure 1).
Although RFLP analysis separated type 1 plasmids into 7
subtypes, based on antimicrobial resistance encoded by
these plasmids, 3 subtypes were observed, conferring
resistance to AMP and Sxt (1b-1e and 1g), AMP, CHL, Sxt,
and TET (1f) and AMP, CHL, KAN, Sxt and TET (1a),
respectively (Table 3). Apparently, the dfrA12-orfF-aadA2-
qacEΔ1-sulI region of class 1 integrons, which is frequently
found in MDR Salmonella [26-28], was located on MDR
plasmid and conferred resistance to Sxt (Table 3). Inser-
tion sequence IS26 existed in all (Table 3) and differed
from plasmids in S. Braenderburg found in Spain [29].
The size change in type 1 plasmids may be due to presence
of multiple IS26 elements that may be involved in plas-
mid rearrangement (Figure 3).
Although conjugation capability of type 2 plasmids was
higher than that of type 1 plasmids, we only identified
coexistence of type 1 and 2 plasmids in three S.
Braenderup isolates, which differed in isolation day and
PFGE pattern (Table 3). Isolate 13 with type 1f and 2a
plasmids was collected in July of 2004 from Taipei. Isolate
32 with type 1d and 2a plasmids and isolate 36 with 1c
and 2b plasmids were collected in March and May of
2005, respectively, from Taichung (Table 3). Only one
isolate 44 with a type 1d plasmid was collected before
those three isolates, in June of 2004 from Taichung. These
results suggest possibly that isolate 32 with A6 genotype
and R6 resistance pattern may be derived from isolate 44
with a type 1 plasmid, A4 genotype and R6 resistance pat-
tern by introduction of a type 2 plasmid. Interestingly,
type 2 plasmids are IncI1  plasmids, carrying the tnpA-
blaCMY-2-blc-sugE structure (Table 3). AmpC β-lactamases
are broadly distributed among the Enteribacteriaceae, and
plasmid-mediated AmpC β-lactamases include ACC, ACT,
CFE, CMY, DHA, FOX, LAT, MIR, and MOX [30]. At least
three transposase associated genetic structures for blaCMY
include ISEcp1-blaCMY-2-blc-sugE, ISCR1-blaCMY-9-yqgF-yqgE
and  IS26-frdC-frdD-ampR-blaCMY-13-blc-sugE-IS26  [30].
Recently, blaCMY has been shown to be broadly spread in
Salmonella worldwide [29,31,32] and to be present in S.
Braenderup [33]. In Taiwan, since we reported the tnpA-
blaCMY-2-blc-sugE structure in S. Choleraesuis in 2004 [34],
this transposon-like element has been found in other Sal-
monella serovars and Enterobacteriaceae [32]. In the present
study, we first reported that S. Braenderup harbors tnpA-
blaCMY-2-blc-sugE  on a type 2 plasmid. Comparing this
plasmid with the 138-kb plasmid pSC138 (accession no.
NC_006856) of S. Choleraesuis, both are IncI1 plasmids
with the tnpA-blaCMY-2-blc-sugE structure. However, type 2
plasmids were conjugative and much smaller in size due
to lack of a 60-kb DNA region with multiple integrons and
transposons, which carry MDR genes [35-37].
Conclusions
Over 95% cases of human salmonellosis surveyed in this
study were caused by 5 Salmonella serogroups: B, C1, C2,
D1, and E1. As two prevalent serogroup C1 serovars, S.
Braenderup and S. Bareiley differed in patients' age groups
and XbaI-PFGE patterns. Both serovars were clonally dis-
seminated and drug-susceptible. However, in S.
Braenderup, cluster A MDR isolates were derived from
susceptible isolates by sequential introduction of two dis-
tinct R plasmids. Type 1 plasmids carry blaTEM, F1A/F1B
replicons, insertion sequence IS26, and a class 1 integron
with a gene cluster comprised of dfrA12-orfF-aadA2-
qacEΔ1-sulI. In contrast, type 2 plasmids consist of IncI1
replicon and tnpA-blaCMY-2-blc-sugE. Although type 2 plas-
mids showed higher conjugation capability, type 1 plas-
mids were the predominant plasmids responsible for
MDR dissemination in S. Braenderup.
Methods
Bacterial isolates
Salmonella isolates were collected from 19 medical centers
and district hospitals located throughout Taiwan from
2004 to 2007. Serotypes of the isolates were determined
in the Salmonella Reference Laboratory of Centers for Dis-
ease Control (CDC), Department of Health, Taiwan, with
antisera purchased from S&A Reagents Lab (Bangkok,
Thailand), Denka Seiken (Tokyo, Japan), Statens Serum
Institut (Copenhagen, Denmark), and a local biotech
company, LTK Biolaboratories (Taoyuan, Taiwan). Phase
induction was performed using a paper-bridged method
developed by the Taiwan CDC [38]. In total, 51 S. Bareilly
isolates and 45 S. Braenderup isolates collected in 2004
and 2005 were selected for further characterization. Iso-
lates were separated into two groups based on their geo-
graphic origin: the north Taiwan group, consisting of
isolates collected from north of Taichung county (includ-
ing Taichung county), and the south Taiwan group, con-
sisting of isolates collected from south of Taichung
county.
Antimicrobial susceptibility testing
Antimicrobial susceptibility testing was performed using
the disc diffusion method in accordance with the guide-BMC Microbiology 2009, 9:264 http://www.biomedcentral.com/1471-2180/9/264
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lines of the CLSI standards [39] with 7 antibiotics: ampi-
cillin (AMP, 50 μg), chloramphenicol (CHL, 20 μg),
kanamycin (KAN, 30 μg), streptomycin (STR, 10 μg), tet-
racycline (TET, 12 μg), trimethoprim-sulfamethoxazole
(Sxt, 23.75/1.25 μg), and quinolone antibiotics including
nalidixic acid (NAL, 30 μg), levofloxacin (LEV, 5 μg) and
moxifloxacin (MOX, 5 μg). The antimicrobials were pur-
chased from BD (Becton Dickinson and Company,
Sparks, Maryland, USA). Escherichia coli ATCC 25922 was
used as the reference strain. An MDR isolate was defined
as having resistance to three or more antibiotics belonging
to different antibiotic classes.
Pulsed-field gel electrophoresis (PFGE)
The PulseNet Standardized Laboratory PFGE Protocol for
Molecular Subtyping of Echerichia coli O157:H7, non-
typhoidal Salmonella serotypes, and Shigella sonnei [40]
was used for analysis of the Salmonella isolates: 10 U of
XbaI were used for the restriction digestion. PFGE images
were analyzed by using the fingerprint analysis software
BioNumerics version 4.5 (Applied Maths). A unique PFGE
pattern was defined as one or two DNA bands differing
between PFGE patterns of two isolates. A dendrogram was
generated by the unweighted pairgroup method with
arithmetic mean (UPGMA) algorithm using the Dice-pre-
dicted similarity value of two Xbal-digested PFGE patterns.
Plasmid profile analysis
Plasmid profiles of each isolate were determined by the
Kado and Liu method [41], and plasmid size was esti-
mated by comparison with the plasmids of two S. Choler-
aesuis strains: OU7085 (50 kb and 6.6 kb) and OU7526
(50 kb and 90 kb).
Restriction fragment length polymorphism (RFLP) and 
antibiotic susceptibility analysis of the MDR-plasmid
Large plasmids (> 50 kb) of 17 AMP and STR-resistant S.
Braenderup isolates were characterized. Plasmid DNA was
purified from resistant wild-type isolates by the alkaline
lysis method [42] and then transformed into the compe-
tent E. coli strain pir116 (STRR), which was prepared by
the CaCl2 method. Transformants were selectively grown
on LB agar plates supplemented with AMP (100 μg/ml)
and further tested for resistance to CHL, TET, and KAN,
but not for resistance to STR, since the recipient strain was
inherently resistant to streptomycin. The antibiotic resist-
ance genes blaTEM, aadA, and blaCMY-2, class 1 integron as
well as the insertion sequence IS26 and its related DNA
fragments were amplified using the primers listed in Table
4. The genes blaSHV and blaCTX-M3 and M14 were also detected
by the multiplex method [43]. The R-plasmids of each
transformant were purified by use of the Geneaid Plasmid
Midi Kit (Geneaid, Taiwan) and were digested with Hin-
dIII (New England Biolabs, USA) to determine similarity.
Plasmid DNA fragments were separated by electrophore-
sis through a 0.6 % SeaKem GTG agarose gel (Cambrex
Bio Science Rockland, Inc., Rockland, ME, USA) at 25 V
for 16 h. The PCR product of class 1 integron was purified
by DNA Clean/Extraction kit (GeneMark, Taiwan) and
sequenced by Mission Biotech co. (Taiwan).
Table 4: The PCR primers for PCR and size of PCR products
Primer Target DNA sequence (5' to 3') Product Sizesize Note
Tem-F blaTEM GAAGATCAGTTGGGTGCACGAGT 550 bp This study
Tem-R CAACTTTATCCGCCTCCATCCAGT
STR-F1 aadA2 AGACGCTCCGCGCTATAGAAGT 203 bp (46)
STR-R1 CGGACCTACCAAGGCAACGCT
CS-F CS region GGCATCCAAGCAGCAAG Variable (47)
CS-R AAGCAGACTTGACCTGA
1.9CS-F Flanking region of CS region CTGCTGCGTAACATCGTTGCT Variable This study
1.9CS-R GGCGAGATCATCAAGTCAGT
ColE1-F ColE1 oriT CAAATGCTGTCCTTCCAGTGT 225 bp This study
ColE1-R CTCAGTTCGGTGTAGGTCGT
F-F IncFI oriT CAACAACGCGCCGACACCGT 288 bp This study
F-R CCCTTCCTGTCGACGCTTCT
R100-F IncF2 oriT CCACCAAAAGCACCACACACT 266 bp This study
R100-R AGACACTCCTAGCAGCGCCT
pSC138-F IncI oriT TGTCACGAACATCTGCCAGT 193 bp This study
pSC138-R GAGAGAAAGTGCCCATGGCT
IS26in-F IS26 GGCACTGTTGCAAAGTTAGC 820 bp DQ390455.1
IS26in-R GGCACTGTTGCAAATAGTCG
IS26out-F Variable GCTAACTTTGCAACAGTGCC Variable DQ390455.1
IS26out-R CGACTATTTGCAACAGTGCC
Tn-F Tn ACCTAGATTCTACGTCAGTAC Variable (35)
AmpC-F AmpC CAAGTTTGATTCCTTGGACTCT AY253913
AmpC-R CTCATCGTCAGTTATTGCAGCT
SugE-R sugE GCCTGATATGTCCTGGATCGTBMC Microbiology 2009, 9:264 http://www.biomedcentral.com/1471-2180/9/264
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Plasmid conjugation and incompatibility group
Transferability of R plasmids from each RFLP group was
determined by performing the conjugation test following
a previously described method [44] with NAL-resistant S.
Typhimurium LBNP4417 as the recipient strain. Briefly,
0.6 ml of overnight culture of donor strain was mixed
with 1 ml of the overnight recipient strain. Then 1 ml fresh
LB broth was added, and the mixture was incubated at
37°C with shaking at 100 rpm for 4 h. The bacterial solu-
tion was diluted at 101, 103, and 105 times with LB broth,
and then 100 μl of the diluted solution was plated on
MacConkey agar supplemented with AMP (100 μg/ml)
and/or NAL (15 μg/ml). Conjugation efficiency was calcu-
lated by determining the number of transconjugants rela-
tive to the total number of recipients. Four primer sets
were used to amplify the oriT  regions of the ColE1, F
(IncFI), R100 (IncFII), and pSC138 (IncI1-like) plasmids
(Table 1). In addition, replicon types of these resistant
plasmids were determined as described by Carattoli et al.
[45].
Statistical analysis
The difference in the antimicrobial resistance rates
between two serovars was analyzed by the independent t
test. P values of < 0.05 were considered significant.
List of abbreviations
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